SUBSCRIBE
4 minutes
Scottish biopharmaceutical firm Aurum Biosciences has successfully raised nearly £730,000 in the initial phase of its latest equity funding for advancing its state-of-the-art therapeutic and diagnostic technology. The funding round – which will be split across two tranches – has be
